Stockscreener 앱 받기
1.13
0.00%
0.00
시간 외 거래:
1.13
전일 마감가:
$1.13
열려 있는:
$1.12
하루 거래량:
336.18K
Relative Volume:
0.40
시가총액:
$148.14M
수익:
$4.35M
순이익/손실:
$-45.53M
주가수익비율:
-1.0463
EPS:
-1.08
순현금흐름:
$-44.79M
1주 성능:
+7.62%
1개월 성능:
+9.71%
6개월 성능:
+9.71%
1년 성능:
+37.02%
1일 변동 폭
$1.119
$1.15
1주일 범위
$1.035
$1.15
52주 변동 폭
$0.80
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
명칭
Lucid Diagnostics Inc
전화
212 949 4319
주소
360 MADISON AVENUE, NEW YORK
LUCD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.13 | 148.14M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
127.78 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.79 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
366.39 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.31 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.85 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 개시 | BTIG Research | Buy |
| 2021-11-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 개시 | Needham | Buy |
Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - marketscreener.com
PAVMED announces 1-for-30 reverse stock split - MSN
PAVmed Announces Reverse Stock Split - marketscreener.com
PAVmed Announces Reverse Stock Split - Benzinga
Ideas Watch: Will Lucid Diagnostics Inc stock see PE expansionWeekly Investment Summary & AI Driven Stock Price Forecasts - moha.gov.vn
Bull Run: Why Lucid Diagnostics Inc stock remains on buy listsJuly 2025 Gainers & Community Verified Trade Signals - moha.gov.vn
Here’s Why Lucid Diagnostics (LUCD) Declined in Q3 - Insider Monkey
Lucid Diagnostics files for $175 mln mixed securities shelf offering - MSN
Can Lucid Diagnostics Inc. stock reach $100 price targetJuly 2025 Momentum & Comprehensive Market Scan Reports - Улправда
What valuation multiples suggest for Lucid Diagnostics Inc. stockJuly 2025 WrapUp & Smart Allocation Stock Tips - DonanımHaber
Can Lucid Diagnostics Inc. stock rebound after recent weakness2025 Trade Ideas & Free Safe Capital Growth Stock Tips - DonanımHaber
How analysts rate Lucid Diagnostics Inc. stock todayInflation Watch & Consistent Return Strategy Ideas - DonanımHaber
Brokerages Set Lucid Diagnostics Inc. (NASDAQ:LUCD) Price Target at $3.94 - Defense World
Lucid Group stock hits 52-week low at $11.46 - Investing.com
Lucid Diagnostics Earnings Notes - Trefis
Can Lucid Diagnostics Inc stock rebound after recent weakness2025 Top Decliners & Verified Momentum Stock Ideas - moha.gov.vn
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Lucid Diagnostics (NASDAQ:LUCD) Using Too Much Debt? - simplywall.st
Ascendiant Capital Markets Issues Positive Forecast for Lucid Diagnostics (NASDAQ:LUCD) Stock Price - Defense World
Lucid Diagnostics Stock (LUCD) Opinions on Recent Clinical Data Release - Quiver Quantitative
Lucid Diagnostics (NASDAQ:LUCD) Given New $8.25 Price Target at Ascendiant Capital Markets - MarketBeat
LUCD FinancialsIncome Statement - Quiver Quantitative
Ascendiant Capital Maintains Lucid Diagnostics (LUCD) Buy Recommendation - Nasdaq
Lucid Diagnostics stock price target raised to $8.25 at Ascendiant Capital By Investing.com - Investing.com South Africa
Lucid Diagnostics stock price target raised to $8.25 at Ascendiant Capital - Investing.com Canada
Lucid Diagnostics files $175M mixed securities shelf - MSN
Lucid Diagnostics reports real-world data on esophageal test device By Investing.com - Investing.com Australia
Lucid Diagnostics (LUCD) Stock: Surge After Real-World EsoGuard Data Breakthrough! - parameter.io
Lucid Diagnostics reports real-world data on esophageal test device - Investing.com
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection - PR Newswire
Lucid Diagnostics (Nasdaq: LUCD) reports 95% EsoCheck success in 11,991 patients - Stock Titan
Lucid Diagnostics Announces $15.3 Million Registered Direct Offe - GuruFocus
A Look at Lucid Diagnostics Inc (LUCD) Shares in the Recent Past Indicates Growth - Setenews
Should I hold or sell Lucid Diagnostics Inc. stock in 2025Weekly Market Outlook & Weekly High Return Stock Opportunities - Newser
Is Lucid Diagnostics, Inc. overvalued or undervalued? - Markets Mojo
Why Lucid Diagnostics Inc. stock appeals to analysts2025 Retail Activity & Safe Investment Capital Preservation Plans - Newser
Lucid Diagnostics (LUCD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Lucid Diagnostics stock falls after pricing capital raise of $15M via stock offering - MSN
Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest shareholders are individual investors with 38% ownership, public companies own 30% - Yahoo Finance
Is Lucid Diagnostics Inc (LUCD) positioned for future growth? - Setenews
Why Being Public Gave PavMed a Competitive Edge - Medical Device and Diagnostic industry
Get in on Lucid Diagnostics Inc’s (LUCD) buy-in window today! - Setenews
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree - PR Newswire
Ranking Lucid Diagnostics Inc. among high performing stocks via tools2025 Top Decliners & AI Powered Trade Plan Recommendations - newser.com
Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Canada
Developing predictive dashboards with Lucid Diagnostics Inc. dataBear Alert & Fast Gain Swing Alerts - newser.com
Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald - Investing.com
Lucid Diagnostics Inc (LUCD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.82%
자본화:
|
볼륨(24시간):